Compositions and methods for treating peripheral arterial disease

The present disclosure provides compositions and methods for treating peripheral arterial disease in a subject by administering an exonucleotide pyrophosphatase phosphodiesterase-1 (ENPP1) agent or an exonucleotide pyrophosphatase phosphodiesterase-3 (ENPP3) agent. 本公开提供了通过施用外核苷酸焦磷酸酯酶磷酸二酯酶-1(ENPP1)药...

Full description

Saved in:
Bibliographic Details
Main Authors THOMPSON DAVID, NITSCHKE YVES, RUETSCH FLORIAN
Format Patent
LanguageChinese
English
Published 07.07.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure provides compositions and methods for treating peripheral arterial disease in a subject by administering an exonucleotide pyrophosphatase phosphodiesterase-1 (ENPP1) agent or an exonucleotide pyrophosphatase phosphodiesterase-3 (ENPP3) agent. 本公开提供了通过施用外核苷酸焦磷酸酯酶磷酸二酯酶-1(ENPP1)药剂或外核苷酸焦磷酸酯酶磷酸二酯酶-3(ENPP3)治疗受试者的外周动脉疾病的组合物和方法。
Bibliography:Application Number: CN202180061245